JIC’s role
On August 10, 2018, JIC and its wholly-owned subsidiary, JIC Huawen Investment Limited, together with Tamar Alliance Partners, Fund I, L.P., completed the acquisition of a 75% stake in Australia Nature's Care Biotech ("ANCB").
Since its acquisition of ANCB, JIC has helped to promote the company’s performance and improve its management team, including setting up a professional team to connect with the Chinese market, improving the incentive and restraint mechanism, integrating the dealership network, expanding the online B2B market as well as constructing offline sales channels in China.